Pharmafile Logo
  • - PMLiVE
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • Communiqué 53 Cover Image

    • Delivering purposeful solutions at Obesity Week 2025

    October 9, 2025 | Obesity Week 

    We’re attending Obesity Week 2025, the world’s leading event dedicated to obesity research and care, to showcase how our integrated expertise is advancing progress in obesity and cardiometabolic health.

    - PMLiVE

    Obesity Week 2025 is the premier global event dedicated to obesity research, prevention, and care – bringing together leading scientists, clinicians, and innovators to advance progress in one of the most dynamic areas of healthcare.​

    At Inizio, we’re uniting science, strategy, and creativity to deliver purposeful solutions across obesity and cardiometabolic health. Our integrated teams collaborate across the full commercialization journey to help clients navigate complexity, unlock value, and enhance outcomes at every stage of development and delivery.​

    Our experience spans the full obesity ecosystem: we’ve supported over 20 leading anti-obesity therapies, partnered on 80% of the largest GLP-1 assets, and worked across 18 specialized services to deliver smarter, connected solutions that make an impact.​

    Visit us at booth #812 to meet our experts and explore how Inizio’s integrated expertise is transforming the future of obesity and cardiometabolic care.​

    If you’d like to meet with us at Obesity Week, please get in touch.

    This content was provided by Inizio

    Company Details

    - PMLiVE

    Inizio

    Email
    Website

     Latest Content from  Inizio 

    Research Partnership sends a cheque for $10,000 to Forever Angels

    Helping them in their mission of caring for and improving the lives of orphans and abandoned infants in Tanzania

    Pharma Market Research Conference, 2018

    We are delighted to be presenting and exhibiting at PMRC, 14-15 February in Newark, NJ.

    Out of the shadows: Mental health in the Asia Pacific region

    In the first of a series of articles exploring mental health in emerging markets we take an in-depth look at the situation in Asia

    Research Partnership has published a new patient Living with Atopic Dermatitis (US) report

    Living with Atopic Dermatitis (AD) is a report based on a new study conducted amongst adult sufferers and parents of child sufferers. The report consists of 45-minute quantitative and 30-minute qualitative...

    Research Partnership has published a new patient Living with Psoriasis (EU) report

    Living with Psoriasis is a report based on a new study conducted in the main 5EU markets and Belgium and the Netherlands (reports can be purchased for either 5EU or 7EU)....

    New opportunities in emerging markets

    Published in Pharma Exec January 2018 by Rachel Howard

    Webinar: Portfolio tracking for success

    Thursday 18th January 2018 11:00 EST / 16:00 GMT / 17:00 CEST

    20 questions: Round-up video

    As it's our 20th year anniversary, we invited our employees to play our version of 20 questions throughout the year - this month we have created a final round-up video showcasing some...

    Patient centricity: Reality or rhetoric?

    Everybody is talking about patient centricity, but what does it mean for those involved in market research, insights and business intelligence?

    Review of Disease Promotion Campaign using Facial Analysis

    Our client had developed a visual and emotion-invoking, online disease awareness campaign aimed at challenging physicians’ current perceptions of treatment. Research was required to understand physicians’ reactions to the campaign...